Ferroptosis-related gene glutathione peroxidase 4 promotes reprogramming of glucose metabolism via Akt–mTOR axis in intrahepatic cholangiocarcinoma
Carcinogenesis · 2024
DOI: 10.1093/carcin/bgad094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2024. Verfasst von Yutaro Hori und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Ferroptosis, Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Grants-in-Aid KAKENHI, Public Trust Surgery Research Fund, Kyoto Healthcare Society Foundation.
Abstract (Originalsprache)
The role of the ferroptosis-related gene glutathione peroxidase 4 (GPX4) in oncology has been extensively investigated. However, the clinical implications of GPX4 in patients with intrahepatic cholangiocarcinoma (ICC) remain unknown. This study aimed to evaluate the prognostic impact of GPX4 and its underlying molecular mechanisms in patients with ICC. Fifty-seven patients who underwent surgical resection for ICC between 2010 and 2017 were retrospectively analyzed. Based on the immunohistochemistry, patients were divided into GPX4 high (n = 15) and low (n = 42) groups, and clinical outcomes were assessed. Furthermore, the roles of GPX4 in cell proliferation, migration and gene expression were analyzed in ICC cell lines in vitro and in vivo. The results from clinical study showed that GPX4 high group showed significant associations with high SUVmax on 18F-fluorodeoxyglucose-positron emission tomography (≥8.0, P = 0.017), multiple tumors (P = 0.004), and showed glucose transporter 1 (GLUT1) high expression with a trend toward significance (P = 0.053). Overall and recurrence-free survival in the GPX4 high expression group were significantly worse than those in the GPX4 low expression group (P = 0.038 and P < 0.001, respectively). In the experimental study, inhibition of GPX4 attenuated cell proliferation and migration in ICC cell lines. Inhibition of GPX4 also decreased the expression of glucose metabolism-related genes, such as GLUT1 or HIF1α. Mechanistically, these molecular changes are regulated in Akt–mechanistic targets of rapamycin axis. In conclusion, this study suggested the pivotal value of GPX4 serving as a prognostic marker for patients with ICC. Furthermore, GPX4 can mediate glucose metabolism of ICC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Medical Life Systems, Faculty of Life and Medical Science, Doshisha University, Kyotanabe, Japan.
- Department of Surgery, Faculty of Medicine, Kochi Medical School, Nankoku, Japan.
ORCID-Profile: Yutaro Hori
Förderung
- Grants-in-Aid KAKENHI
- Public Trust Surgery Research Fund
- Kyoto Healthcare Society Foundation
Zitieren
APA
Hori, Y., Yoh, T., Nishino, H., Okura, K., Kurimoto, M., Takamatsu, Y., Satoh, M., Nishio, T., Koyama, Y., Ishii, T., Iwaisako, K., Seo, S., & Hatano, E. (2024). Ferroptosis-related gene glutathione peroxidase 4 promotes reprogramming of glucose metabolism via Akt–mTOR axis in intrahepatic cholangiocarcinoma. Carcinogenesis. https://doi.org/10.1093/carcin/bgad094
Vancouver
Hori Y, Yoh T, Nishino H, Okura K, Kurimoto M, Takamatsu Y, et al. Ferroptosis-related gene glutathione peroxidase 4 promotes reprogramming of glucose metabolism via Akt–mTOR axis in intrahepatic cholangiocarcinoma. Carcinogenesis. 2024. doi:10.1093/carcin/bgad094
BibTeX
@article{Hori2024,
author = {Hori, Yutaro and Yoh, Tomoaki and Nishino, Hiroto and Okura, Keisuke and Kurimoto, Makoto and Takamatsu, Yuichi and Satoh, Motohiko and Nishio, Takahiro and Koyama, Yukinori and Ishii, Takamichi and Iwaisako, Keiko and Seo, Satoru and Hatano, Etsuro},
title = {Ferroptosis-related gene glutathione peroxidase 4 promotes reprogramming of glucose metabolism via Akt–mTOR axis in intrahepatic cholangiocarcinoma},
journal = {Carcinogenesis},
year = {2024},
doi = {10.1093/carcin/bgad094}
}
EUVIMED